XML 85 R57.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE CAPITAL - Summary of warrants by expiry period (Details) - Common Share Purchase Warrants
$ / shares in Units, $ in Thousands
Mar. 31, 2025
CAD ($)
shares
$ / shares
Mar. 31, 2024
shares
Mar. 31, 2023
shares
Disclosure of classes of share capital [line items]      
Warrants outstanding (in shares) 2,796,197 2,796,197 611,329
Warrants exercisable (in shares) 2,796,197    
Weighted average of exercisable price (in CAD per share) | $ / shares $ 24.03    
Estimated grant date fair value | $ $ 27,594    
Weighted average remaining of outstanding contractual life 4 years 1 month 9 days    
August 4, 2028      
Disclosure of classes of share capital [line items]      
Warrants outstanding (in shares) 635,887    
Warrants exercisable (in shares) 635,887    
Weighted average of exercisable price (in CAD per share) | $ / shares $ 15.2    
Estimated grant date fair value | $ $ 4,578    
Weighted average remaining of outstanding contractual life 3 years 4 months 6 days    
May 14, 2029      
Disclosure of classes of share capital [line items]      
Warrants outstanding (in shares) 1,754,386    
Warrants exercisable (in shares) 1,754,386    
Weighted average of exercisable price (in CAD per share) | $ / shares $ 19.38    
Estimated grant date fair value | $ $ 17,842    
Weighted average remaining of outstanding contractual life 4 years 1 month 13 days    
June 15, 2030      
Disclosure of classes of share capital [line items]      
Warrants outstanding (in shares) 336,843    
Warrants exercisable (in shares) 336,843    
Weighted average of exercisable price (in CAD per share) | $ / shares $ 9.50    
Estimated grant date fair value | $ $ 3,891    
Weighted average remaining of outstanding contractual life 5 years 2 months 15 days    
August 20, 2030      
Disclosure of classes of share capital [line items]      
Warrants outstanding (in shares) 38,818    
Warrants exercisable (in shares) 38,818    
Weighted average of exercisable price (in CAD per share) | $ / shares $ 24.32    
Estimated grant date fair value | $ $ 936    
Weighted average remaining of outstanding contractual life 5 years 4 months 20 days    
November 15, 2030      
Disclosure of classes of share capital [line items]      
Warrants outstanding (in shares) 30,263    
Warrants exercisable (in shares) 30,263    
Weighted average of exercisable price (in CAD per share) | $ / shares $ 9.50    
Estimated grant date fair value | $ $ 347    
Weighted average remaining of outstanding contractual life 5 years 7 months 17 days